Historical record - last NADAC publication: 6/17/2020
Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0299 per EA under NDC 53746021901. Its NADAC has been published 337 times since Jan 22, 2014.
Strength
850 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746021901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2020
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077880On Market Since
12/17/2012
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 337 times since Jan 22, 2014, and over the history we have for it it has declined 31.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0299 per EA |
|---|---|
| All-time high | $0.0436 (Feb 12, 2014) |
| All-time low | $0.0270 (Apr 17, 2019) |
| Median price | $0.0319 |
| Average price | $0.0329 |
| Largest weekly change | -15.4% (Aug 19, 2015) |
| Weeks tracked | 337 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0299 per EA (NDC 53746021901), effective Jul 1, 2020.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 31.3%. It has been tracked across 337 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Jan 22, 2014, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0270 (Apr 17, 2019) to a high of $0.0436 (Feb 12, 2014), with a median of $0.0319 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL 850 MG TABLET, is $0.0247 per EA — about 18% below METFORMIN HCL 850 MG TABLET.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 53746021901) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification